Artemisia para Inflamación sistémica

Artemisia finita — 10 estudios científicos revisados

Moderate

¿Sirve Artemisia para inflamación sistémica?

Contiene compuestos antioxidantes y antiinflamatorios que ayudan a reducir la respuesta inflamatoria en el organismo.

Compuestos activos involucrados: Terpenoides, Flavonoides, Aceites esenciales, Lactonas sesquiterpénicas, Cumarinas, Fenoles

Evidencia Científica

Los siguientes estudios han investigado la relación entre Artemisia y inflamación sistémica:

Attenuation of quorum sensing regulated virulence functions and biofilm of pathogenic bacteria by medicinal plant Artemisia annua and its phytoconstituent 1, 8-cineole.

The emergence of multidrug resistance (MDR) in bacterial pathogens is a serious public health concern. A significant therapeutic target for MDR infections is the quorum sensing-regulated bacterial pathogenicity. Determining the anti-quorum sensing abilities of certain medicinal plants against bacterial pathogens as well as the in-silico interactions of particular bioactive phytocompounds with QS and biofilm-associated proteins were the objectives of the present study. In this study, 6 medicinal plants were selected based on their ethnopharmacological usage, screened for Anti-QS activity and Ar

PubMed: 37728140

An ethnobotanical survey on the medicinal and edible plants used by the Daur people in China.

BACKGROUND: The Daur people are one of the 55 minority ethnic groups in China and have lived in Northern China for 300 years. In traditional Daur medicine, medicinal and edible plants (MEPs) are utilised for health benefits and therapeutic purposes; however, related ethnobotanical knowledge is rarely reported, which is disadvantageous for the sustainable development of these MEPs. METHODS: Semi-structured interviews with 122 informants, six focus group discussions, and a resource survey were conducted in a Daur minority nationality area in Inner Mongolia from 2015 to 2020, and the data statist

PubMed: 38790060

Neuroprotective and anti-epileptic potentials of genus Artemisia L.

The Genus Artemisia L. is one of the largest genera in the Asteraceae family growing wild over in Europe, North America, and Central Asia and has been widely used in folk medicine for the treatment of various ailments. Phytochemical and psychopharmacological studies indicated that the genus Artemisia extracts contain various antioxidant and anti-inflammatory compounds and possess antioxidant, anti-inflammatory, antimicrobial, antimalarial, and antitumor activity. Recently, increasing experimental studies demonstrated that many Artemisia extracts offer a great antiepileptic potential, which was

PubMed: 36339595

Ethnobotanical survey of the traditional antiparasitic use of medicinal plants in humans and animals in Laghouat (Southern Algeria).

BACKGROUND AND AIM: An ethnobotanical survey was carried out among the inhabitants of the Aflou region of Laghouat (Southern Algeria). This study was considered as a first step toward the identification of new bioactive antiparasitic molecules. The preservation and documentation of this traditional knowledge will ensure its continuity and transmission from one generation to another, especially because of the emergence of resistant parasites and the lack of references caused by the lack of work in this area; therefore, we intended to inventory and collect the maximum amount of information on me

PubMed: 37041995

Artemisia: a promising plant for the treatment of cancer.

Due to the promising features of the ancient herbal plant Artemisia, its biologic activity has been investigated for use in modern medicine. In this regard, Artemisia and its active phytochemicals have been introduced as having antimalarial, antioxidant, cytotoxic, antispasmodic, anthelmintic, neuroprotective, anti-inflammatory, and antimicrobial agents. In the case of cancer treatment, the plant species and its bioactive compounds target multiple pathways. Here we reviewed the scientific literature published up until 2018, which have explained the cytotoxic activity of the Artemisia species a

PubMed: 31784199

Seguridad y Precauciones

La seguridad del uso de Artemisia (Artemisia finita) debe abordarse con extrema cautela, ya que su perfil toxicológico depende estrictamente de la dosis y la duración del tratamiento. En el caso de mujeres embarazadas o en periodo de lactancia, el uso de esta planta está contraindicado debido a la evidencia de toxicidad reproductiva. Los compuestos bioactivos de la especie pueden atravesar la barrera placentaria o pasar a la leche materna, lo que podría interferir con el desarrollo fetal o neonatal. Dado que estudios toxicológicos han señalado riesgos de toxicidad reproductiva en dosis elevadas, el uso durante la gestación debe evitarse para prevenir posibles malformaciones o complicaciones en el desarrollo del infante. Para niños menores de 12 años, la seguridad no está establecida y se recomienda la abstención total. Los sistemas fisiológicos en desarrollo son más susceptibles a los efectos neurotóxicos y metabólicos de los terpenoides y otros metabolitos secundarios presentes en la planta.

Ver perfil de seguridad completo de Artemisia →

Otras plantas estudiadas para Inflamación sistémica

Perfil completo: Ver todos los usos y evidencia de Artemisia →